Literature DB >> 14523465

High incidence of trisomies 1q, 9q, and 11q in multiple myeloma: results from a comprehensive molecular cytogenetic analysis.

P Liebisch, C Wendl, A Wellmann, A Kröber, G Schilling, H Goldschmidt, H Einsele, C Straka, M Bentz, S Stilgenbauer, H Döhner.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 14523465     DOI： 10.1038/sj.leu.2403153

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  8 in total

1.  The molecular classification of multiple myeloma.

Authors:  Fenghuang Zhan; Yongsheng Huang; Simona Colla; James P Stewart; Ichiro Hanamura; Sushil Gupta; Joshua Epstein; Shmuel Yaccoby; Jeffrey Sawyer; Bart Burington; Elias Anaissie; Klaus Hollmig; Mauricio Pineda-Roman; Guido Tricot; Frits van Rhee; Ronald Walker; Maurizio Zangari; John Crowley; Bart Barlogie; John D Shaughnessy
Journal:  Blood       Date:  2006-05-25       Impact factor: 22.113

2.  Gain of chromosome 1q portends worse prognosis in multiple myeloma despite novel agent-based induction regimens and autologous transplantation.

Authors:  Gunjan L Shah; Heather Landau; Dory Londono; Sean M Devlin; Satyajit Kosuri; Alexander M Lesokhin; Nikoletta Lendvai; Hani Hassoun; David J Chung; Guenther Koehne; Suresh C Jhanwar; Ola Landgren; Ross Levine; Sergio A Giralt
Journal:  Leuk Lymphoma       Date:  2017-01-12

3.  Amplification of 1q21 and other abnormalities in multiple myeloma patients from a tertiary hospital in singapore.

Authors:  Alvin S T Lim; Sathish Krishnan; Tse Hui Lim; Karen See; Yit Jun Ng; Yu Min Tan; Natasha Choo; Lai Ching Lau; Sim Leng Tien; Jun Ma; Daryl Tan
Journal:  Indian J Hematol Blood Transfus       Date:  2013-09-04       Impact factor: 0.900

4.  Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem-cell transplantation.

Authors:  Ichiro Hanamura; James P Stewart; Yongsheng Huang; Fenghuang Zhan; Madhumita Santra; Jeffrey R Sawyer; Klaus Hollmig; Maurizio Zangarri; Mauricio Pineda-Roman; Frits van Rhee; Federica Cavallo; Bart Burington; John Crowley; Guido Tricot; Bart Barlogie; John D Shaughnessy
Journal:  Blood       Date:  2006-05-16       Impact factor: 22.113

5.  Rapid assessment of hyperdiploidy in plasma cell disorders using a novel multi-parametric flow cytometry method.

Authors:  Surbhi Sidana; Dragan Jevremovic; Rhett P Ketterling; Nidhi Tandon; Angela Dispenzieri; Morie A Gertz; Patricia T Greipp; Linda B Baughn; Francis K Buadi; Martha Q Lacy; William Morice; Curtis Hanson; Michael Timm; David Dingli; Suzanne R Hayman; Wilson I Gonsalves; Prashant Kapoor; Robert A Kyle; Nelson Leung; Ronald S Go; John A Lust; S Vincent Rajkumar; Shaji K Kumar
Journal:  Am J Hematol       Date:  2019-01-08       Impact factor: 10.047

6.  CD38 - Negative Anaplastic Plasma Cell Myeloma: A Rare Case Report.

Authors:  An Thi Vinh Do; Le Lan Anh
Journal:  Cureus       Date:  2022-01-03

Review 7.  Multiple Myeloma With Amplification of Chr1q: Therapeutic Opportunity and Challenges.

Authors:  Romanos Sklavenitis-Pistofidis; Gad Getz; Irene Ghobrial; Maria Papaioannou
Journal:  Front Oncol       Date:  2022-07-14       Impact factor: 5.738

8.  Deletions of CDKN2C in multiple myeloma: biological and clinical implications.

Authors:  Paola E Leone; Brian A Walker; Matthew W Jenner; Laura Chiecchio; Gianpaolo Dagrada; Rebecca K M Protheroe; David C Johnson; Nicholas J Dickens; Jose Luis Brito; Monica Else; David Gonzalez; Fiona M Ross; Selina Chen-Kiang; Faith E Davies; Gareth J Morgan
Journal:  Clin Cancer Res       Date:  2008-10-01       Impact factor: 12.531
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.